Pages that link to "Q30671120"
Jump to navigation
Jump to search
The following pages link to Assessing the effect of hormonal contraception on HIV acquisition in observational data: challenges and recommended analytic approaches (Q30671120):
Displaying 25 items.
- Contraceptive methods and risk of HIV acquisition or female-to-male transmission (Q27027323) (← links)
- Hormonal contraceptive use and women's risk of HIV acquisition: a meta-analysis of observational studies (Q30660068) (← links)
- Injectable and oral contraceptives and risk of HIV acquisition in women: an analysis of data from the MDP301 trial (Q30823365) (← links)
- Oral and injectable contraceptive use and HIV acquisition risk among women in four African countries: a secondary analysis of data from a microbicide trial (Q31014284) (← links)
- Bacterial vaginosis and the risk of trichomonas vaginalis acquisition among HIV-1-negative women (Q34025858) (← links)
- Are hormonal contraceptive users more likely to misreport unprotected sex? Evidence from a biomarker validation study in Zimbabwe (Q34173869) (← links)
- Ethical issues for late-stage trials of multipurpose prevention technologies for HIV and pregnancy (Q34451550) (← links)
- Tenofovir disoproxil fumarate intravaginal ring protects high-dose depot medroxyprogesterone acetate-treated macaques from multiple SHIV exposures. (Q34673931) (← links)
- Hormonal contraception does not increase women's HIV acquisition risk in Zambian discordant couples, 1994-2012 (Q35639676) (← links)
- Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study (Q35817142) (← links)
- Hormonal Contraceptive Use Among HIV-Positive Women and HIV Transmission Risk to Male Partners, Zambia, 1994-2012. (Q37252680) (← links)
- An updated systematic review of epidemiological evidence on hormonal contraceptive methods and HIV acquisition in women (Q37409664) (← links)
- Differential glucocorticoid receptor-mediated effects on immunomodulatory gene expression by progestin contraceptives: implications for HIV-1 pathogenesis (Q38189088) (← links)
- Long-acting hormonal contraception (Q38655482) (← links)
- Use of injectable hormonal contraception and women's risk of herpes simplex virus type 2 acquisition: a prospective study of couples in Rakai, Uganda (Q38858718) (← links)
- Use of injectable hormonal contraception and HSV-2 acquisition in a cohort of female sex workers in Vancouver, Canada (Q39207555) (← links)
- Effects of intrauterine contraception on the vaginal microbiota (Q40168592) (← links)
- Objective Measurement of Inaccurate Condom Use Reporting Among Women Using Depot Medroxyprogesterone Acetate for Contraception (Q40517790) (← links)
- Contraception and sexually transmitted infections: risks and benefits, hypotheses and evidence (Q41148937) (← links)
- Hormonal Contraception and HIV-1 Acquisition: Biological Mechanisms (Q47198102) (← links)
- Is a lower-dose, subcutaneous contraceptive injectable containing depot medroxyprogesterone acetate likely to impact women's risk of HIV? (Q49838895) (← links)
- Concordance of self-reported hormonal contraceptive use and presence of exogenous hormones in serum among African women (Q50142380) (← links)
- Hormonal contraceptive methods and HIV: research gaps and programmatic priorities. (Q53728030) (← links)
- Plasma concentration of injectable contraceptive correlates with reduced cervicovaginal growth factor expression in South African women (Q92380763) (← links)
- Hormonal contraception and HIV acquisition among women: an updated systematic review (Q92526598) (← links)